FDA NDC Directory · JSON-LD · Markdown

Cyklokapron

NDC 0013-1114 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nametranexamic acid
Labeler / ManufacturerPfizer Laboratories Div Pfizer Inc
Marketing categoryNew Drug Application (innovator) · App NDA019281
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsTRANEXAMIC ACID (100 mg/mL)
Marketing started19861230
Package count2

External sources

Source: openFDA. Public-domain (CC0).